Since in melanoma patients’ high monomeric IL-15 serum levels have been reported to correlate with a poor clinical outcome (20), we asked what could be the consequences of a too-high and constant production of the IL-15/IL-15Rα complex. This evidence concerns the gene IL15 and melanoma.